Evidence map›Paper›PMID 25724814›Full record

ArticleObesity surgery2015

The Role of FTO and Vitamin D for the Weight Loss Effect of Roux-en-Y Gastric Bypass Surgery in Obese Patients.

Marcus Bandstein, Bernd Schultes, Barbara Ernst, Martin Thurnheer, Helgi B Schiöth, Christian Benedict

Open access · hybridAbstract read
In one paragraph

Article in Obesity surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 7 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 7 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The importance of gene-environment interactions in human obesity.Clinical science (London, England : 1979) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marcus BandsteinDepartment Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden. marcus.bandstein@neuro.uu.se.
Bernd SchultesInterdisciplinary Obesity Center, eSwiss Medical & Surgical Center, St. Gallen, Switzerland. bernd.schultes@stephanshorn.ch.
Barbara ErnstInterdisciplinary Obesity Center, eSwiss Medical & Surgical Center, St. Gallen, Switzerland. barbara.ernst@stephanshorn.ch.
Martin ThurnheerInterdisciplinary Obesity Center, eSwiss Medical & Surgical Center, St. Gallen, Switzerland. martin.thurnheer@stephanshorn.ch.
Helgi B SchiöthDepartment Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden. helgi.schioth@neuro.uu.se.
Christian BenedictDepartment Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden. christian.benedict@neuro.uu.se.
eSwiss Medical and Surgical Center · CHUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA recent study in children demonstrated that the rs9939609 single-nucleotide polymorphism in the fat mass and obesity (FTO) gene influences prospective weight gain, however, only in those who were vitamin D-deficient. If this might also be the case for Roux-en-Y gastric bypass (RYGB), surgery-induced weight loss is however unknown. The objective of this study is to examine if the magnitude of RYGB surgery-induced weight loss after 2 years depends on patients' FTO rs9939609 genotype (i.e., TT, AT, and AA) and presurgery vitamin D status (<50 nmol/L equals deficiency).

methodsBefore and at 24 months after RYGB surgery, BMI was measured in 210 obese patients (mean BMI 45 kg/m(2), 72 % females). Serum 25-hydroxyvitamin D3 levels were also repeatedly measured. Following surgery, vitamin D was supplemented. Possible weight loss differences between genotypes were tested with multiple linear regressions.

resultsThe per-allele effect of each FTO A-allele on excessive BMI loss (EBMIL) was 3 % (P = 0.02). When split by baseline status, the EBMIL of vitamin D-deficient patients carrying AA exceeded that of vitamin D-deficient patients carrying TT by ~14 % (P = 0.03). No such genotypic differences were found in patients without presurgery vitamin D deficiency. Post-surgery serum levels of vitamin D did not differ between groups.

conclusionsOur data suggest that presurgery vitamin D levels influence the size of genotype effects of FTO rs9939609 on RYGB surgery-induced weight loss in obese patients.

Indexed as

Anastomosis, Roux-en-YGastric BypassWeight LossAdultAlpha-Ketoglutarate-Dependent Dioxygenase FTODietary SupplementsFemaleGenotypeHumansMaleObesity, MorbidPolymorphism, Single NucleotidePostoperative PeriodProspective StudiesProteinsVitamin DAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanProteinsVitamin DBariatric surgeryFTORYGBVitamin DWeight loss

Identifiers

PMID25724814
PMCPMC4595530
OpenAlexW2157697389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.